Royal DSM completes acquisition of 91.75% in Shandong ICD High Performance Fiber Co. Ltd.

07-Oct-11

Royal DSM N.V. (DSM), the global Life Sciences and Materials Sciences company, announced that it has successfully completed the acquisition of a majority share of 91.75% in Shandong ICD High Performance Fiber Co. Ltd. (ICD), based in Laiwu, Shandong province, China, as announced on 17 February 2011. Financial terms of the acquisition are not disclosed. ICD is a manufacturer of UHMWPE (ultra-high molecular weight polyethylene) fiber and a strong player in the high-performance fiber market in China. The acquisition brings complementary manufacturing and technology assets to DSM and substantially strengthens the company's presence in this key market. Nico Gerardu, member of the DSM Managing Board and responsible for DSM's Performance Materials cluster, commented: "We are delighted to have completed this acquisition and we welcome ICD to DSM. This acquisition reflects our continued commitment to China and our strategy of investing in High Growth Economies as well as in partners with proven success and high growth potential." Gerard de Reuver, President of DSM Dyneema, added: "China is a major market for UHMWPE fiber production and consumption. This acquisition marks a milestone in the global development of DSM Dyneema and provides a stronger platform for continued growth and leadership in the China market."